Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Oct 31, 2019 · 10-Q · 31 days after period end · 0001171843-19-007045
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$1.54M | -$4.51M | -$12.31M | -$7.11M |
| EPS Diluted | -$0.92 | -$0.25 | -$1.08 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Oct 31, 2019 · 31 d after period end
